• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者术前磁共振成像中伴随NME的临床意义。

The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients.

作者信息

Gweon Hye Mi, Jeong Joon, Son Eun Ju, Youk Ji Hyun, Kim Jeong-Ah, Ko Kyung Hee

机构信息

Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

PLoS One. 2017 May 30;12(5):e0178445. doi: 10.1371/journal.pone.0178445. eCollection 2017.

DOI:10.1371/journal.pone.0178445
PMID:28558007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5448772/
Abstract

PURPOSE

To investigate the significance of accompanying NME in invasive ductal carcinoma (IDC) on preoperative MR imaging and assess the factors affecting the significance.

METHODS

Between January 2015 and February 2016, 163 consecutive patients with IDC who underwent preoperative MR imaging and subsequent surgery were enrolled and reviewed. Index cancer mass size and total extent with accompanying NME on MR images was measured and compared with pathologic size. Positive NME was defined as pathological result of IDC or DCIS. To identify affecting factors associated with frequency of accompanying NME on MR and positive pathologic result, clinicopathologic features were compared between breast cancers with NME and without NME, and between breast cancers with positive NME and negative NME using the Student t-test or Chi-square test.

RESULTS

Of the 163 invasive breast cancers, 123(75.5%) cancers presented as only mass feature and 40(24.5%) cancers had accompanying NME around the index mass. Of the 40 accompanying NME, 22 (55%) had positive pathologic results and 18 (45%) had negative results. The HER2 positive status was significantly associated with positive pathologic results of accompanying NME (P = .016).

CONCLUSION

Accompanying NME on preoperative MR imaging showed malignant pathologic results in 55%. The HER2 positive IDC was more frequently accompanied by malignant NME.

摘要

目的

探讨浸润性导管癌(IDC)中伴随非肿块强化(NME)在术前磁共振成像(MR)中的意义,并评估影响该意义的因素。

方法

纳入2015年1月至2016年2月期间连续163例行术前MR成像及后续手术的IDC患者并进行回顾性分析。测量MR图像上肿瘤原发灶大小及伴随NME的总体范围,并与病理大小进行比较。NME阳性定义为IDC或导管原位癌(DCIS)的病理结果。为确定与MR上伴随NME频率及病理阳性结果相关的影响因素,采用Student t检验或卡方检验,比较有NME和无NME的乳腺癌之间,以及NME阳性和阴性的乳腺癌之间的临床病理特征。

结果

163例浸润性乳腺癌中,123例(75.5%)仅表现为肿块特征,40例(24.5%)肿瘤原发灶周围伴有NME。40例伴有NME的病例中,22例(55%)病理结果为阳性,18例(45%)为阴性。HER2阳性状态与伴随NME的病理阳性结果显著相关(P = .016)。

结论

术前MR成像中伴随的NME有55%显示为恶性病理结果。HER2阳性的IDC更常伴有恶性NME。

相似文献

1
The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients.乳腺癌患者术前磁共振成像中伴随NME的临床意义。
PLoS One. 2017 May 30;12(5):e0178445. doi: 10.1371/journal.pone.0178445. eCollection 2017.
2
Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.术前乳腺 MRI 伴随非肿块样强化的乳腺 X 线摄影诊断价值。
Acta Radiol. 2022 Aug;63(8):1032-1042. doi: 10.1177/02841851211030771. Epub 2021 Jul 14.
3
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.乳腺钼靶摄影、临床检查、超声及磁共振成像在乳腺癌术前评估中的诊断准确性
Radiology. 2004 Dec;233(3):830-49. doi: 10.1148/radiol.2333031484. Epub 2004 Oct 14.
4
MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study.根据激素受体状态分析HER2阳性乳腺癌的磁共振成像和乳腺钼靶成像特征:一项回顾性对比研究
Acta Radiol. 2017 Jul;58(7):792-799. doi: 10.1177/0284185116673119. Epub 2016 Oct 17.
5
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.术前乳腺 MRI 中与恶性指数乳腺癌肿块相邻的非肿块样增强的放射-病理相关性。
Radiol Imaging Cancer. 2024 Mar;6(2):e230060. doi: 10.1148/rycan.230060.
6
Breast cancer molecular subtype classifier that incorporates MRI features.结合MRI特征的乳腺癌分子亚型分类器。
J Magn Reson Imaging. 2016 Jul;44(1):122-9. doi: 10.1002/jmri.25119. Epub 2016 Jan 12.
7
Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?“非肿块型”与“肿块型”浸润性导管乳腺癌的预后因素是否存在差异?
Eur J Radiol. 2013 Sep;82(9):1404-9. doi: 10.1016/j.ejrad.2013.03.006. Epub 2013 Mar 27.
8
Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.术前磁共振成像背景实质信号增强比:与保乳手术后乳腺原位癌患者局部复发的关系。
Radiology. 2014 Mar;270(3):699-707. doi: 10.1148/radiol.13130459. Epub 2013 Oct 28.
9
Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?乳腺磁共振成像检测到而乳腺X线摄影未检测到的多中心癌:重要与否?
Radiology. 2016 May;279(2):378-84. doi: 10.1148/radiol.2015150796. Epub 2015 Nov 25.
10
Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.乳腺癌动态对比增强磁共振成像中的正性强化积分值:导管原位癌与浸润性导管癌的比较
Eur J Radiol. 2014 Aug;83(8):1363-7. doi: 10.1016/j.ejrad.2014.05.006. Epub 2014 May 16.

引用本文的文献

1
MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas.乳腺癌免疫表型的 MRI 特征,重点关注腔面雌激素受体低阳性浸润性癌。
Sci Rep. 2024 Aug 20;14(1):19305. doi: 10.1038/s41598-024-69778-6.
2
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.术前乳腺 MRI 中与恶性指数乳腺癌肿块相邻的非肿块样增强的放射-病理相关性。
Radiol Imaging Cancer. 2024 Mar;6(2):e230060. doi: 10.1148/rycan.230060.
3
Comparison of BSGI and MRI as Approaches to Evaluating Residual Tumor Status after Neoadjuvant Chemotherapy in Chinese Women with Breast Cancer.乳腺特异性伽马成像(BSGI)与磁共振成像(MRI)用于评估中国乳腺癌女性新辅助化疗后残余肿瘤状态的比较
Diagnostics (Basel). 2021 Oct 6;11(10):1846. doi: 10.3390/diagnostics11101846.
4
MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.基于MRI的放射组学特征作为接受新辅助化疗的HER2阳性浸润性乳腺癌的预后生物标志物
Cancer Manag Res. 2020 Oct 27;12:10603-10613. doi: 10.2147/CMAR.S271876. eCollection 2020.
5
Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo.功能化纳米颗粒靶向抗体增强乳腺癌体内成像。
J Nanobiotechnology. 2020 Sep 18;18(1):135. doi: 10.1186/s12951-020-00695-2.
6
Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Patients with Invasive Lobular Carcinoma.术前磁共振成像特征与浸润性小叶癌患者切缘阳性的关系。
Korean J Radiol. 2020 Aug;21(8):946-954. doi: 10.3348/kjr.2019.0674.
7
Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?术前 MRI 的强化类型能否反映浸润性乳腺癌的预后因素和手术结果?
Eur Radiol. 2019 Dec;29(12):7000-7008. doi: 10.1007/s00330-019-06236-2. Epub 2019 Jun 11.

本文引用的文献

1
Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.保乳手术后手术切缘的预测因素:一项基于大样本人群的队列研究。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):627-633. doi: 10.1245/s10434-016-5532-5. Epub 2016 Sep 2.
2
Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?哪些因素会影响乳腺癌肿瘤大小测量的MRI与病理结果的一致性?
Eur Radiol. 2016 May;26(5):1457-65. doi: 10.1007/s00330-015-3935-5. Epub 2015 Aug 14.
3
Magnetic resonance imaging of breast cancer: factors affecting the accuracy of preoperative lesion sizing.乳腺癌的磁共振成像:影响术前病灶大小测量准确性的因素
Acta Radiol. 2015 Mar;56(3):260-8. doi: 10.1177/0284185114524089. Epub 2014 Feb 13.
4
Ductal carcinoma in situ of the breasts: review of MR imaging features.乳腺导管原位癌:MR 成像特征综述。
Radiographics. 2013 Oct;33(6):1569-88. doi: 10.1148/rg.336125055.
5
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
6
Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis.磁共振成像在原发性乳腺癌患者术前评估中的应用:系统评价诊断准确性和荟萃分析。
Eur Radiol. 2012 Jan;22(1):26-38. doi: 10.1007/s00330-011-2238-8. Epub 2011 Aug 17.
7
Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast.磁共振成像(MRI)与常规成像在年轻女性或乳腺致密患者乳腺癌术前分期中的作用。
Eur J Surg Oncol. 2011 Mar;37(3):199-204. doi: 10.1016/j.ejso.2010.12.011. Epub 2011 Jan 14.
8
Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.基于网络调查的三种乳腺导管原位癌分类系统的可重复性研究。
Pathol Res Pract. 2010 Oct 15;206(10):705-11. doi: 10.1016/j.prp.2010.06.004. Epub 2010 Jul 21.
9
False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.增强型乳腺磁共振成像的假阳性发现:BI-RADS 描述符研究。
AJR Am J Roentgenol. 2010 Jun;194(6):1658-63. doi: 10.2214/AJR.09.3486.
10
Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.磁共振成像筛查新诊断乳腺癌女性对侧乳腺:增量癌症检测的系统评价和荟萃分析及其对手术管理的影响。
J Clin Oncol. 2009 Nov 20;27(33):5640-9. doi: 10.1200/JCO.2008.21.5756. Epub 2009 Oct 5.